The FDA says ZOLL Medical’s Chelmsford facility failed to meet device quality and reporting rules. The company has fifteen business days to outline fixes or face enforcement.

Nano Dimension signed a non‑binding term sheet to merge with Infinite Epigenetics in a proposed $890M stock deal that would pivot the Waltham company into AI‑powered health diagnostics. The combined firm would seek the Nasdaq ticker IEAI and access to more than $400M in cash at closing.

Phase II results from Boston suggest the century‑old BCG TB vaccine can lower insulin needs for some people with type 1 diabetes. Early data are promising but experts say larger trials are required.